查看文章

Submit Manuscript| http://medcraveonline. com research. This initiative, led by Vice President Joe Biden, aims to make therapies available to a large number of cancer patients and is projected to improve cancer prevention and detection it at an early stage. Recently (May 2016), the White House released The Federal Big Data Research and Development Strategic Plan, which provide guidance for developing or expanding Federal Big Data research and development (R&D) plans.

The Accelerating Medicines Partnership (AMP), a new venture involving the US National Institutes of Health (NIH), 10 biopharmaceutical companies, and several nonprofit organizations, has an initial fund of $230 Million. The overall goals are to transform the current approaches for diagnostics and treatments to a new dimension using big data analytics by jointly identifying and validating promising biological targets of disease. The initial therapeutic areas include Alzheimer’s disease, Type 2 diabetes and two autoimmune disorders, rheumatoid arthritis and systemic lupus erythematosus (lupus). The European drug research consortium projects that they will invest more than $5 billion in the next several years to apply big data techniques termed “Big Data for Better Outcomes,” to speed up clinical drug trials while developing a sustainable healthcare delivery system. In the UK, the National Institute for Health Research (NIHR) has put in place a series of initiatives to help exploit the nation’s strengths in technology, medical research and healthcare data. The Genomics England Project is expected to generate a vast amount of genetic information from 100,000 patients with …